Allscripts Healthcare Solutions, Inc. (MDRX) Position Decreased by Alliancebernstein L.P.

Alliancebernstein L.P. cut its position in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 3.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 134,614 shares of the software maker’s stock after selling 4,910 shares during the period. Alliancebernstein L.P. owned 0.07% of Allscripts Healthcare Solutions worth $1,707,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in MDRX. GSA Capital Partners LLP bought a new position in shares of Allscripts Healthcare Solutions during the fourth quarter valued at $118,000. Tudor Investment Corp Et Al raised its position in Allscripts Healthcare Solutions by 36.3% in the fourth quarter. Tudor Investment Corp Et Al now owns 22,900 shares of the software maker’s stock worth $234,000 after buying an additional 6,100 shares during the last quarter. Guggenheim Capital LLC raised its position in Allscripts Healthcare Solutions by 4.4% in the fourth quarter. Guggenheim Capital LLC now owns 149,708 shares of the software maker’s stock worth $1,529,000 after buying an additional 6,301 shares during the last quarter. Teachers Retirement System of The State of Kentucky raised its position in Allscripts Healthcare Solutions by 11.7% in the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 45,000 shares of the software maker’s stock worth $459,000 after buying an additional 4,700 shares during the last quarter. Finally, Thrivent Financial for Lutherans raised its position in Allscripts Healthcare Solutions by 7.7% in the fourth quarter. Thrivent Financial for Lutherans now owns 31,450 shares of the software maker’s stock worth $321,000 after buying an additional 2,260 shares during the last quarter.

Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ MDRX) traded down 1.69% during mid-day trading on Thursday, reaching $12.78. 1,847,084 shares of the company’s stock traded hands. The company has a 50 day moving average of $12.51 and a 200 day moving average of $12.20. The company’s market cap is $2.31 billion. Allscripts Healthcare Solutions, Inc. has a 12 month low of $9.80 and a 12 month high of $13.70.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.15 by $0.04. Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The business had revenue of $426.10 million during the quarter, compared to the consensus estimate of $424.94 million. During the same quarter in the prior year, the business posted $0.14 earnings per share. Allscripts Healthcare Solutions’s quarterly revenue was up 10.2% compared to the same quarter last year. Analysts expect that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current fiscal year.

A number of analysts have commented on MDRX shares. Zacks Investment Research upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, April 19th. Leerink Swann lowered shares of Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and cut their price target for the company from $15.00 to $13.00 in a report on Monday, June 19th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $13.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. Maxim Group reissued a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. Finally, BidaskClub upgraded shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, June 24th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $14.59.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.